2009
The most important news at ASCO 2009
DeVita V. The most important news at ASCO 2009. Nature Reviews Clinical Oncology 2009, 6: 371-371. PMID: 19561629, DOI: 10.1038/nrclinonc.2009.93.Peer-Reviewed Original ResearchOff-label use of approved drugs
DeVita V. Off-label use of approved drugs. Nature Reviews Clinical Oncology 2009, 6: 181-181. PMID: 19333219, DOI: 10.1038/nrclinonc.2009.41.Peer-Reviewed Original Research
2007
The Provenge® decision
DeVita V. The Provenge® decision. Nature Reviews Clinical Oncology 2007, 4: 381-381. PMID: 17554239, DOI: 10.1038/ncponc0854.Peer-Reviewed Original Research
2006
A step in the right direction
DeVita V. A step in the right direction. Nature Reviews Clinical Oncology 2006, 3: 641-641. PMID: 17139311, DOI: 10.1038/ncponc0669.Peer-Reviewed Original Research
2005
Should the FDA be the doctor of last resort?
DeVita V. Should the FDA be the doctor of last resort? Nature Reviews Clinical Oncology 2005, 2: 423-423. PMID: 16264991, DOI: 10.1038/ncponc0292.Peer-Reviewed Original Research